MyFinsight
Home
Blog
About
Cash and cash
equivalents
$278,729K
(32.03%↑ Y/Y)
Short-term investments
$249,864K
(-35.54%↓ Y/Y)
Prepaid expenses and
other current assets
$39,084K
(-5.75%↓ Y/Y)
Equity investments
$4,133K
(-43.15%↓ Y/Y)
Restricted cash and cash
equivalents, current
$1,929K
(-97.81%↓ Y/Y)
Total current assets
$573,739K
(-22.02%↓ Y/Y)
Long-term investments
$475,016K
(66.03%↑ Y/Y)
Operating right-of-use
assets
$59,391K
(-8.42%↓ Y/Y)
Property and equipment,
net
$50,430K
(-17.05%↓ Y/Y)
Other assets
$24,647K
(86.89%↑ Y/Y)
Goodwill
$16,937K
(0.00%↑ Y/Y)
Intangible assets, net
$7,702K
(-3.70%↓ Y/Y)
Restricted cash and cash
equivalents, noncurrent
$6,944K
(-0.17%↓ Y/Y)
Total assets
$1,214,806K
(1.87%↑ Y/Y)
Total liabilities and
stockholders equity
$1,214,806K
(1.87%↑ Y/Y)
Total stockholders
equity
$982,493K
(3.70%↑ Y/Y)
Total liabilities
$232,313K
(-5.20%↓ Y/Y)
Accumulated deficit
-$1,243,386K
(-25.38%↓ Y/Y)
Accumulated other
comprehensive loss
-$4,602K
(-107.20%↓ Y/Y)
Additional paid-in capital
$2,230,464K
(14.89%↑ Y/Y)
Total current
liabilities
$94,961K
(-9.56%↓ Y/Y)
Operating lease
liabilities, noncurrent
$84,137K
(-9.92%↓ Y/Y)
Contingent consideration
obligation, noncurrent
$34,340K
(2.14%↑ Y/Y)
Other long-term
liabilities
$18,875K
(44.85%↑ Y/Y)
Common stock, 0.0001
par value...
$17K
(21.43%↑ Y/Y)
Accrued and other
liabilities
$77,207K
(-6.60%↓ Y/Y)
Accounts payable
$17,754K
(45.12%↑ Y/Y)
Back
Back
Balance Sheet
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)
source: myfinsight.com